RIYADH, KSA, Aug 28, 2026 – (ACN Newswire) –The Riyadh Global Medical Biotechnology Summit has actually released the clinical program for its 4th edition, and the names on it come from individuals presently choosing what medication will have the ability to perform in the next twenty years. Sixty verified speakers and mediators from eleven nations are called throughout 3 days, from 14 to 16 September 2026, at the Sofitel Riyadh Hotel and Convention Centre.
Amongst them are Prof. Jin-Soo Kim of KAIST, whose deal with mitochondrial DNA modifying reaches beyond CRISPR; Dr. Matthew H. Porteus of Stanford University, engineering hereditary circuits into cell-based medications; Dr. Alex Shalek of MIT; Prof. Vijay Kuchroo of Harvard Medical School; Prof. Keith T. Flaherty of the Massachusetts General Hospital Cancer Center and President of the American Association for Cancer Research; Prof. George F. Gao of the Chinese Academy of Sciences; President Mitsuo Ochi of Hiroshima University; and Dr. Zdenko Herceg of the International Agency for Research on Cancer.
They are signed up with by the individuals who move science into the world. Dr. Steve Yang, Co-CEO of WuXi AppTec, and Mr. Alec Reynolds of Flagship Pioneering open the program on international collaboration. Mr. Kasim Kutay, Chief Executive Officer of Novo Holdings, speaks on where capital needs to go next. Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, provides the closing keynote. Along with them stand the Saudi organizations developing a biotechnology sector in genuine time: KAIMRC, Lifera, HUMAIN, SPIMACO, KAUST, the Saudi Food and Drug Authority, and Astronaut Rayyanah Barnawi on what the human body immune system carries out in area.
The program stumbles upon 6 tracks: expert system in biotechnology, multi-omics, biotech financial investment, immunology, bioengineering and artificial biology, and biotech labor force advancement. Its specifying function is that discovery and shipment share the exact same phase. Genome modifying and population genomics sit next to guideline, domestic production, and procurement, and in numerous sessions the researchers and the regulators are on the very same panel. That is the facility of the Kingdom’s National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040: a discovery deserves just as much as the system offered to bring it to a client.
“Biotechnology is where the health of every country will be chosen over the next twenty years. Saudi Arabia has actually picked not to enjoy that occur from a range. We are developing the labs, the production, the regulative communities, and above all, the bio-workforce skill. And we are constructing it in collaboration with the world, under one roofing system.
That is what this Summit is for. Its styles highlight where medication and biotechnology assemble to form the future of biosciences.
Discoveries and developments are changing how we look after clients. The variety of emerging innovations and treatments is producing substantial chances to check out, advance, invest, and equate clinical development into much better health results. Please join us in Riyadh this September.” H.E. Prof. Bandar bin Abdulmohsen Al-Knawy, Chief Executive Officer of Health Affairs, Ministry of National Guard, and President, King Saud bin Abdulaziz University for Health Sciences
The Summit is arranged and monitored by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment and Invest Saudi acting as tactical partners. The 4th edition is anticipated to invite more than 15,000 visitors, over 200 biotechnology and health care brand names, and delegations from more than 70 nations, under the style Building the Foundations of Biotechnology Excellence.
The complete clinical program is connected and readily available at rgmbs.org, where registration is open for delegates, exhibitors, and market partners. Follow the Summit at #RGMBS 2026.
For more info relating to top programing go to: https://rgmbs.org/program#conference-agenda
About the Riyadh Global Medical Biotechnology Summit
The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia’s flagship platform for medical biotechnology, assembling the worldwide clinical, financial investment, and policy neighborhoods in Riyadh. Organized and monitored by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the objectives of the National Biotechnology Strategy and supports the Kingdom’s development as a worldwide location for health development. The 4th edition occurs from 14 to 16 September 2026 in Riyadh.
For Media Inquiry
Email: [email protected]
Telephone: +966 559 810 777
Subject: Press release summary